ACAD
30.94
-0.14
-0.45%
AEMD
1.51
-0.02
-1.31%
APRI
1.48
-0.01
-0.67%
ARNA
20.26
-0.27
-1.32%
ATEC
1.94
+0.02
+1.04%
CNAT
5.15
+0.14
+2.79%
CRXM
0.17
+0.01
+4.20%
CYTX
0.311
-0.011
-3.5039%
DXCM
73.06
-0.14
-0.19%
GNMK
9.54
-0.06
-0.63%
HALO
11.9
+0.02
+0.17%
ILMN
190.68
+1.36
+0.72%
INNV
0.108
+0.008
+7.5000%
INO
5.46
+0.01
+0.18%
ISCO
1.25
-0.07
-5.30%
ISIS
57.56
0.00
0.00%
LGND
126.55
+0.29
+0.23%
LPTN
2.93
-2.93
-100.00%
MBVX
0.51
+0.01
+2.00%
MEIP
2.6
-0.08
-2.99%
MNOV
4.97
0.00
0.00%
MRTX
5.45
-0.15
-2.68%
MSTX
0.13
-0.01
-5.28%
NBIX
52.13
-0.02
-0.04%
NUVA
64.48
+0.42
+0.66%
ONCS
0.89
-0.03
-3.2500%
ONVO
1.81
-0.04
-2.16%
OREX
2.39
-0.03
-1.24%
OTIC
20.25
+1.5
+8.00%
QDEL
32.77
+0.16
+0.49%
RCPT
231.96
0.00
0.00%
RGLS
0.846
+0.02
+2.4573%
RMD
73.44
+0.37
+0.51%
SCIE
0
0.00
-33.3333%
SPHS
1.82
-0.08
-4.21%
SRNE
1.7
-0.05
-2.86%
TROV
0.82
-0.01
-1.17%
VICL
2.34
-0.09
-3.70%
VOLC
18
0.00
0.00%
ZGNX
12.3
+0.05
+0.41%
ACAD
30.94
-0.14
-0.45%
AEMD
1.51
-0.02
-1.31%
APRI
1.48
-0.01
-0.67%
ARNA
20.26
-0.27
-1.32%
ATEC
1.94
+0.02
+1.04%
CNAT
5.15
+0.14
+2.79%
CRXM
0.17
+0.01
+4.20%
CYTX
0.311
-0.011
-3.5039%
DXCM
73.06
-0.14
-0.19%
GNMK
9.54
-0.06
-0.63%
HALO
11.9
+0.02
+0.17%
ILMN
190.68
+1.36
+0.72%
INNV
0.108
+0.008
+7.5000%
INO
5.46
+0.01
+0.18%
ISCO
1.25
-0.07
-5.30%
ISIS
57.56
0.00
0.00%
LGND
126.55
+0.29
+0.23%
LPTN
2.93
-2.93
-100.00%
MBVX
0.51
+0.01
+2.00%
MEIP
2.6
-0.08
-2.99%
MNOV
4.97
0.00
0.00%
MRTX
5.45
-0.15
-2.68%
MSTX
0.13
-0.01
-5.28%
NBIX
52.13
-0.02
-0.04%
NUVA
64.48
+0.42
+0.66%
ONCS
0.89
-0.03
-3.2500%
ONVO
1.81
-0.04
-2.16%
OREX
2.39
-0.03
-1.24%
OTIC
20.25
+1.5
+8.00%
QDEL
32.77
+0.16
+0.49%
RCPT
231.96
0.00
0.00%
RGLS
0.846
+0.02
+2.4573%
RMD
73.44
+0.37
+0.51%
SCIE
0
0.00
-33.3333%
SPHS
1.82
-0.08
-4.21%
SRNE
1.7
-0.05
-2.86%
TROV
0.82
-0.01
-1.17%
VICL
2.34
-0.09
-3.70%
VOLC
18
0.00
0.00%
ZGNX
12.3
+0.05
+0.41%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …